Dimethylamine

Dimethylamine

SCHEMBL7481385

CNC.Cc1nc2c(N)cccc2[nH]1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 4/20 0.54
▸ TDP1 Q9NUW8 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CHEK1 O14757 1/20 0.47
▸ ATP4A P20648 1/20 0.42
▸ ATP4B P51164 1/20 0.42
▸ DRD2 P14416 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ HPGD P15428 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ DHODH Q02127 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ADRB2 P07550 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013125 0.94 PARP1 (0.59) PARP1TDP1MEN1POLBGAA
Hydrochloric Acid SCHEMBL6120896 0.93 PARP1 (0.57) PARP1TDP1MEN1POLBGAA
SCHEMBL7963795 0.75 TDP1 (0.50) PARP1TDP1MEN1POLBGAA
SCHEMBL3287778 0.75 MEN1 (0.58) PARP1TDP1MEN1POLBGAA
SCHEMBL30291834 0.75 MEN1 (0.58) PARP1TDP1MEN1POLBGAA
SCHEMBL353891 0.75 PARP1 (0.56) PARP1GAA
SCHEMBL20936149 0.75 PARP1 (0.56) PARP1GAADRD2DRD4DRD3
SCHEMBL30132388 0.75 CHEK1 (0.47) PARP1TDP1MEN1POLBGAA
SCHEMBL6994637 0.74 CHEK1 (0.56) PARP1TDP1MEN1POLBGAA
SCHEMBL6999051 0.73 CHEK1 (0.56) TDP1MEN1POLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 — — US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 — — US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 — — EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 — — WO disclosed
Send feedback